Bowling Portfolio Management LLC United Therapeutics Corp Transaction History

Bowling Portfolio Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	BUY	$174.81 - $241.14 $978,761 - $1.35 Million	5,599 New	5,599 $1.32 Million
Q2 2018 Aug 06, 2018	SELL	$101.14 - $118.31 $2.8 Million - $3.28 Million	-27,691 Closed	0 $0
Q1 2018 Apr 25, 2018	BUY	$107.21 - $151.94 $2.97 Million - $4.21 Million	27,691 New	27,691 $3.11 Million
Q4 2017 Jan 22, 2018	SELL	$118.58 - $151.28 $3.1 Million - $3.95 Million	-26,117 Closed	0 $0
Q3 2017 Oct 16, 2017	BUY	$114.6 - $136.81 $2.99 Million - $3.57 Million	26,117	26,117 $3.06 Million

672

42.4M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.5B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Bowling Portfolio Management LLC, based on Form 13F filings with the SEC.

Stay updated on Bowling Portfolio Management LLC with notifications on news.